Fort Worth-based Biotechnology innovator, EOSERA Inc., announced Monday, April 9, that Earwax MD will enhance its offering for audiologists and hearing aid centers at the annual audiology meeting, AAA 2018, in Nashville, a news release said.
Eosera will sell product directly and via various resellers for sale in-clinic. The company will also offer a sneak peek at one of several products to come, such as WaxBlaster MD, a new rinsing device meant to be used after cleaning the ear canal with Earwax MD. At the audiology conference attendees can obtain more information about Earwax MD and WaxBlaster MD at Booth 434.
“Since last year, the market has responded remarkably well to Earwax MD,” Elyse Dickerson, Co-founder & CEO of Eosera Inc, said in the release. “In retailers carrying the product, dollar sales are up over 18% in the ear care category. This growth is primarily driven by the introduction of Earwax MD. Over 18 million people a year seek medical treatment for earwax impaction and it remains the number one reason that hearing aids fail to work properly.”
Joe Griffin, Eosera co-founder and CSO, said the company is positioning itself as the “go-to resource for education and information on ear health.” He explained that the company plans to continue to invest in clinical studies that test Eoseras’ products’ safety and efficacy.
“Audiologists have been looking for an easier way to treat patients with impacted earwax. Until now, Audiologists often perform a manual extraction of the impacted wax, which can be very painful and time consuming,” Griffin said. “Now, audiologists and hearing aid centers can use Earwax MD in their offices and also sell the product so that patients can self-treat in the comfort of their own homes prior to their appointments to fit for hearing aids.”
For more information, visit earcaremd.com.
